Login / Signup
Targeting the SARS-CoV-2 3CLpro and NO/cGMP/PDE5 pathway in COVID-19: a commentary on PDE5 inhibitors.
Milad Shirvaliloo
Published in:
Future cardiology (2021)
Keyphrases
</>
sars cov
respiratory syndrome coronavirus
nitric oxide
coronavirus disease
cancer therapy